1,006 filings
8-K/A
JNJ
Johnson & Johnson
16 Apr 24
Johnson & Johnson Reports Q1 2024 Results
12:16pm
8-K
JNJ
Johnson & Johnson
16 Apr 24
Johnson & Johnson Reports Q1 2024 Results
7:06am
DFAN14A
SWAV
Shockwave Medical Inc.
5 Apr 24
Additional proxy materials by non-management
5:29pm
PX14A6G
National Legal & Policy Center
27 Mar 24
Letter to shareholders
9:48am
ARS
2023 FY
JNJ
Johnson & Johnson
13 Mar 24
Annual report to shareholders
7:42am
DEFA14A
ty6150m9
13 Mar 24
Additional proxy soliciting materials
7:39am
DEFA14A
1gv e3u17x
13 Mar 24
Additional proxy soliciting materials
7:37am
DFAN14A
6g09d4 hb62k
15 Feb 24
Additional proxy materials by non-management
5:23pm
DFAN14A
qy993
29 Jan 24
Additional proxy materials by non-management
4:50pm
8-K
t4f6ozmx
23 Jan 24
Johnson & Johnson Reports Q4 and Full-Year 2023 Results
7:45am
DFAN14A
lj3z0
9 Jan 24
Additional proxy materials by non-management
5:08pm
DFAN14A
wjdzi1wjoaor6
8 Jan 24
Additional proxy materials by non-management
5:22pm
DEFA14A
l35aj80qh0 ykc2et85
8 Jan 24
Additional proxy soliciting materials
8:22am
8-K
lfoa1m9ieuzdw
5 Dec 23
Johnson & Johnson Names Eugene A. Woods, Chief Executive Officer of Advocate Health, to its Board of Directors
4:42pm
8-K
lfrdryu7c 9s
5 Dec 23
Johnson & Johnson Announces Key Drivers for Long-Term Competitive Growth at Enterprise Business Review
7:52am
8-K
2s6tllw cwln
30 Nov 23
Strengthens position in high-growth MedTech segments
4:30pm
8-K
ibw1vng9g r2gpe
27 Nov 23
Departure of Directors or Certain Officers
4:56pm